BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen.
P310
Sofort GIFTINFORMATIONSZENTRUM/Arzt/ anrufen.
P314
Bei Unwohlsein ?rztlichen Rat einholen / ?rztliche Hilfe hinzuziehen.
P501
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen.
Atazanavir (BMS-232632, III), an azapeptide HIV
protease inhibitor, has been developed and launched by
Bristol-Myers Squibb (BMS), under worldwide license from
Novartis, for the treatment of HIV infection. Atazanavir
was launched in the US as Reyataz™ in July 2003.
Chemische Eigenschaften
Off-White Solid
Verwenden
Atazanavir is a HIV protease inhibitor with Ki of 2.66 nM
Atazanavir sulfate Upstream-Materialien And Downstream Produkte
Atazanavir sulfateQ: What is
Atazanavir sulfate Q: What is the CAS Number of
Atazanavir sulfate Q: What is the storage condition of
Atazanavir sulfate Q: What are the applications of
Atazanavir sulfate
Atazanavir Sulfate (1044334)
229975-97-7
C38H52N6O7H2SO4
Inhibitor
Atazanavir
Antiviral Agents
Inhibitors
peptides
BMS-232632-05, Reyataz
229975-97-7
Copyright 2019 ? ChemicalBook. All rights reserved
Product Name*
CAS.No
Inquiry Amount*
Port*
Inquiry Description*
+Add Attachment(File Format: Jpg, Gif, Png, PDF,Zip,Txt,doc or xls Max Size: 3MB)